Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Mr. Jorge  O'Hara

Vice President of Marketing, Business Development & Strategy

Dr. Sumaira  MacDonald M.D., Ph.D.

Executive Medical Director

Mr. Richard M. Ruedy

Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance

Mr. Charles S. McKhann

Chief Executive Officer

Ms. Mhairi L. Jones

Chief Accounting Officer & Vice President of Finance

Ms. Alison  Highlander

Vice President of Human Resources

Mr. Lucas W. Buchanan

Chief Financial Officer & Chief Operating Officer

Mr. Kevin M. Klemz

EVice President, Chief Legal Officer & Secretary

Ms. Tammy  Leitsinger

Compliance Officer & Vice President of Medical Affairs

Mr. Andrew S. Davis

Chief Commercial Officer

Medizinische Geräte

Silk Road Medical, Inc

Silk Road Medical, Inc Management-Struktur

Informationen zum Management